Filing Details
RHYTHM PHARMACEUTICALS, INC. (NASDAQ:RYTM) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNASDAQ:RYTM
RHYTHM PHARMACEUTICALS, INC. (RYTM) Reports Material Event to SEC
Filing Details RHYTHM PHARMACEUTICALS, INC. (NASDAQ:RYTM) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market…
Market Context
RHYTHM PHARMACEUTICALS, INC.'s stock currently trades at $105.78 with a market capitalization of $7.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for RHYTHM PHARMACEUTICALS, INC.'s stock.
All SEC filings for RHYTHM PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RYTM Stock Page
Frequently Asked Questions
Where can I read RYTM's SEC filings?
Browse all filings on our RYTM SEC filings page.
What types of SEC filings does RHYTHM PHARMACEUTICALS, INC. file?
Public companies like RHYTHM PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.